Researchers use live virus to identify 30 existing drugs that could treat COVID-19 | Sanford Burnham Prebys
A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus | Journal of Virology
Live "attenuated" influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2
How Long Can a Virus “Live” Outside the Body? | Office for Science and Society - McGill University
Chinese Scientists Propose a New Live-Virus Flu Vaccine
Chinese scientists propose a new live-virus flu vaccine - Global Health Press
Live Attenuated Influenza Vaccine [LAIV] (The Nasal Spray Flu Vaccine) | CDC
New Vaccines and Vectors | BioDiem
Vaccines | Free Full-Text | Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children - ScienceDirect
Generation of reassortant live attenuated influenza vaccine (LAIV).... | Download Scientific Diagram
LA Public Health on Twitter: "The COVID-19 Vaccine cannot give you COVID-19. The current vaccines don't include the virus in any form - no live virus, no weakened virus, no dead virus.
What's the Difference Between Active, Inactive, mRNA, and Other Types of Vaccines? • Meridian Clinical Research
Frontiers | Advances in Development and Application of Influenza Vaccines
Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice | mBio
Schematic diagram of LAIV vaccine seed strain preparation using reverse... | Download Scientific Diagram
PLLAV, A PLASMID-BASED LIVE-ATTENUATED VACCINE TECHNOLOGY - The Neyts-lab of Virology, Antiviral Drug & Vaccine Research
Viruses | Free Full-Text | Novel Approaches for The Development of Live Attenuated Influenza Vaccines
Are Flu Shots 'Live Virus' Vaccines or Not?
How to Live With a Virus - POZ
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding - ScienceDirect
Generation of a live attenuated influenza A vaccine by proteolysis targeting | Nature Biotechnology